ATE327771T1 - Verfahren zur herstellung ursodeoxycholsäure enthaltender pharmazeutischer zusammensetzungen in flüssiger form - Google Patents
Verfahren zur herstellung ursodeoxycholsäure enthaltender pharmazeutischer zusammensetzungen in flüssiger formInfo
- Publication number
- ATE327771T1 ATE327771T1 AT00830302T AT00830302T ATE327771T1 AT E327771 T1 ATE327771 T1 AT E327771T1 AT 00830302 T AT00830302 T AT 00830302T AT 00830302 T AT00830302 T AT 00830302T AT E327771 T1 ATE327771 T1 AT E327771T1
- Authority
- AT
- Austria
- Prior art keywords
- ursodeoxycholic acid
- pharmaceutical compositions
- compositions containing
- liquid form
- producing pharmaceutical
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00830302A EP1147779B1 (de) | 2000-04-20 | 2000-04-20 | Verfahren zur Herstellung ursodeoxycholsäure enthaltender pharmazeutischer Zusammensetzungen in flüssiger Form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE327771T1 true ATE327771T1 (de) | 2006-06-15 |
Family
ID=8175298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00830302T ATE327771T1 (de) | 2000-04-20 | 2000-04-20 | Verfahren zur herstellung ursodeoxycholsäure enthaltender pharmazeutischer zusammensetzungen in flüssiger form |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1147779B1 (de) |
| AT (1) | ATE327771T1 (de) |
| DE (1) | DE60028339T2 (de) |
| DK (1) | DK1147779T3 (de) |
| ES (1) | ES2264925T3 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220100927A (ko) * | 2019-11-22 | 2022-07-18 | 실파 메디케어 리미티드 | 우르소데옥시콜린산의 주입가능한 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5522616A (en) * | 1978-08-04 | 1980-02-18 | Tokyo Tanabe Co Ltd | Bile acid inclusion compound and injection containing the same |
| JPS62153220A (ja) * | 1985-12-27 | 1987-07-08 | Tokyo Tanabe Co Ltd | 胆汁酸内用水剤 |
| EP0640344B1 (de) * | 1993-08-30 | 1998-10-07 | Medichemie Ag | Ursodeoxycholsäure enthaltendes Arzneimittel in flüssiger Darreichungsform |
| EP1113785B1 (de) * | 1998-07-24 | 2005-04-13 | Seo Hong Yoo | Klare wässrige lösungen enthaltend gallensäuren |
-
2000
- 2000-04-20 AT AT00830302T patent/ATE327771T1/de not_active IP Right Cessation
- 2000-04-20 DK DK00830302T patent/DK1147779T3/da active
- 2000-04-20 EP EP00830302A patent/EP1147779B1/de not_active Expired - Lifetime
- 2000-04-20 ES ES00830302T patent/ES2264925T3/es not_active Expired - Lifetime
- 2000-04-20 DE DE60028339T patent/DE60028339T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE60028339T2 (de) | 2007-05-10 |
| EP1147779B1 (de) | 2006-05-31 |
| EP1147779A1 (de) | 2001-10-24 |
| ES2264925T3 (es) | 2007-02-01 |
| DE60028339D1 (de) | 2006-07-06 |
| DK1147779T3 (da) | 2006-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE386736T1 (de) | Verfahren zur herstellung von benzimidazol-2-yl - chinolinonderivaten | |
| DE60107450D1 (de) | Verfahren zur herstellung von fluoroelastomeren | |
| ATE222899T1 (de) | Verfahren zur herstellung von reinem citalopram | |
| ATE488484T1 (de) | Schwefel-enthaltende düngelmittelzusammensetzung und verfahren zur herstellung derselben | |
| DE60121970D1 (de) | Verfahren zur herstellung von pfropfcopolymeren und daraus hergestellte zusammensetzungen | |
| DE60212699D1 (de) | Verfahren zur herstellung eines verbundes | |
| ATE309257T1 (de) | Verfahren zur herstellung von amin-platin- komplexen | |
| AT7110U9 (de) | Verfahren zur herstellung von amlodipinmaleat | |
| DE60000364D1 (de) | Verfahren zur herstellung von 5-cyanophthalid | |
| ATE281448T1 (de) | Verfahren zur herstellung von citalopram | |
| DE502005000428D1 (de) | Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen | |
| DE59905324D1 (de) | Dendrimere fullerenderivate, verfahren zur herstellung und verwendung als neuroprotektiva | |
| ATE306491T1 (de) | Verfahren zur herstellung von wasserfreiem azithromycin | |
| ATE293595T1 (de) | Thyroidhormon-analoga und verfahren zu ihrer herstellung | |
| ATE331804T1 (de) | Verfahren zur herstellung von ansamitocin | |
| DE60134344D1 (de) | Verfahren zur herstellung von anagrelid | |
| ATE328885T1 (de) | Verfahren zur herstellung von sulfonamid- substituierten imidazotriazinonen | |
| ATE262576T1 (de) | Verfahren zur herstellung von weichmittelzusammensetzungen | |
| DE69906593D1 (de) | Verfahren zur herstellung von 8-chinolinolato metallkomplexen | |
| ATE491463T1 (de) | Verfahren zur herstellung von alpha (2) makroglobulin-antigen-molekül-komplexen | |
| DE50104557D1 (de) | Neue beta-amyloid inhibitoren, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| ATE389645T1 (de) | Verfahren zur herstellung von citalopram | |
| ATE327771T1 (de) | Verfahren zur herstellung ursodeoxycholsäure enthaltender pharmazeutischer zusammensetzungen in flüssiger form | |
| DE60041067D1 (de) | Verfahren zur herstellung hochreiner nicht toxischer toxinfragmente | |
| DE60134415D1 (de) | Verfahren zur herstellung von wäscheweichmacherzusammensetzungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1147779 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |